Clinical Trials Browser

Phase 1 × INDUSTRY × simtuzumab × Clear all

NCT01323933 2012-05-03

First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors

Phase 1 Completed

Neoplasms